Paradigm Capital Management Inc’s GenMark Diagnostics, Inc GNMK Stock Holding History

Paradigm Capital Management Inc’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-733,300	Closed	-$17.5M	–	155
2021 Q1	$17.5M	Buy	733,300 +112,500	+18%	+$2.09M	0.91%	37
2020 Q4	$9.06M	Buy	620,800 +424,700	+217%	+$5.63M	0.54%	49
2020 Q3	$2.79M	Buy	196,100 +2,400	+1%	+$36.7K	0.23%	77
2020 Q2	$2.85M	Buy	193,700 +75,000	+63%	+$762K	0.26%	75
2020 Q1	$489K	Buy	118,700 +18,600	+19%	+$87.2K	0.06%	116
2019 Q4	$481K	Buy	100,100 +55,400	+124%	+$306K	0.04%	133
2019 Q3	$271K	Buy	44,700 +25,000	+127%	+$156K	0.02%	141
2019 Q2	$127K	Hold	19,700	–	–	0.01%	155
2019 Q1	$140K	Hold	19,700	–	–	0.01%	160
2018 Q4	$96K	Hold	19,700	–	–	0.01%	157
2018 Q3	$144K	Buy	19,700 +4,800	+32%	+$35.2K	0.01%	168
2018 Q2	$95K	Buy	+14,900	New	+$98.5K	0.01%	162

Paradigm Capital Management Inc's GNMK Position: Q2 2021 in Review

Paradigm Capital Management Inc sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 733,300 shares — an estimated $17.5M sold.

Paradigm Capital Management Inc first reported a position in GNMK in Q2 2018 and held it in 12 quarters. The position peaked at $17.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Paradigm Capital Management Inc reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Paradigm Capital Management Inc sold 733,300 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $17.5M.
Paradigm Capital Management Inc first reported a position in GenMark Diagnostics, Inc in Q2 2018 and held it in 12 quarters.
Paradigm Capital Management Inc's GenMark Diagnostics, Inc position peaked at $17.5M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Paradigm Capital Management Inc's 13F filing for Q2 2021, filed 5 Aug 2021.